Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 8, 1996, Pages 1040-1046

  Capell, Warren H ^a   Zambon, Alberto ^a   Austin, Melissa A ^b   Brunzell, John D ^a   Hokanson, John E ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

apoB; density gradient ultracentrifugation; gradient gel electrophoresis; LDL subclass phenotype B; triglyceride

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ESTER; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; DENSITY GRADIENT CENTRIFUGATION; FEMALE; GEL ELECTROPHORESIS; HEART INFARCTION; HUMAN; LIPID COMPOSITION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029813739     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.8.1040     Document Type: Article

References (53)

1. Nelson CA, Morris MD. The ultracentrifugal heterogeneity of serum low density lipoproteins in normal humans. Biochem Med. 1977;18:1-9.
2. Rubenstein B. Heterogeneity of human plasma low density lipoprotein. Can J Biochem. 1978;56:977-980.
3. Shen MMS, Krauss RM, Lindgren FT, Forte TM. Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res. 1981;22:236-244.
4. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982;23:97-104.
5. Lee DM, Downs D. A quick and large-scale density gradient subfractionation method for low density lipoproteins. J Lipid Res. 1982;23:14-27.
6. Fisher WR. Heterogeneity of plasma low density lipoprotein: manifestations of the physiologic phenomenon in man. Metabolism. 1983;32:283-291.
7. Swinkels DW, Hak-Lemmers HLM, Demacker PNM. Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions. J Lipid Res. 1987;28:1233-1239.
8. Teng B, Thompson GR, Sniderman AD, Forte TM, Krauss RM, Kwiterovich PO Jr. Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. P roc Natl Acad Sci U S A. 1983;80:6662-6666.
9. Chapman MJ, Laplaud PM, Luc G, Forgez P, Bruckert E, Goulinet S, Lagrange D. Furtherresolution of the low density lipoprotein spectrum in normal human plasma: physiochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. J Lipid Res. 1988;29:442-458.
10. Coresh J, Kwiterovich PO Jr. Smith HH, Bachorik PS. Association of plasma TG concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res. 1993;34:1687-1697.
11. Austin MA, King M-C, Vranizan KM, Newman B, Krauss RM. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet. 1988;43:838-846.
12. Crouse JR, Parks JS, Schey HM. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res. 1985;26:566-574.
13. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
14. Tornvall P, Karpe F, Carlson LA, Hamsten A. Relationship of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis. 1991;90:67-80.
15. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12:187-195.
16. Jaakkola O, Solakivi T, Tertov VV, Orekhov AN, Miettinen TA, Nikkari T. Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease. Coron Artery Dis. 1993;4:379-385.
17. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 1994;106:241-253.
18. Krauss RM, Stampfer MJ, Blanche PJ, Holl LG, Ma J, Hennekens CH. A prospective study of LDL particle diameter and risk of myocardial infarction. Circulation. 1994;90:I-460. Abstract.
19. Selby JV, Austin MA, Newman B. Zhang D, Quesenberry CP Jr, Mayer EJ, Krauss RM. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 1993;88:382-387.
20. Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest. 1993;92:141-146.
21. Fujimoto WY, Abbate SL, Kahn SE, Hokanson JE, Brunzell JD. The visceral adiposity syndrome in Japanese-American men. Obes Res. 1994;2:364-371.
22. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb. 1992;12:1496-1502.
23. Stewart MW, Laker MF, Dyer RG, Game F, Mitcheson J, Winocour PH, Alberti KGMM. Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. Arterioscler Thromb. 1993;13:1046-1052.
24. Austin MA, Mykkänen L, Kuusisto J, Edwards KL, Nelson C, Haffner SM. Pyörälä K, Laakso M. Prospective study of small LDLs as a risk factor for non-insulin-dependent diabetes mellitus in elderly men and women. Circulation. 1995;92:1770-1778.
25. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495-506.
26. Austin MA, Hokanson JE. Brunzell JD. Low-density lipoprotein subclasses: methodological approaches and clinical significance. Curr Opin Lipidol. 1994;5:395-403.
27. La Belle M, Krauss RM. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. J Lipid Res. 1990;31:1577-1588.
28. Hokanson JE, Krauss RM, Albers JJ, Austin MA, Brunzell JD. LDL physical and chemical properties in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 1995;15:452-459.
29. McNamara JR, Jenner JL, Li Z, Wilson PWF, Schaefer EJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Anerioscler Thromb. 1992;12:1284-1290.
30. Milne RW, Marcel YL. Monoclonal antibodies against human low density lipoproteins: stoichiometric binding studies using Fab fragments. FEBS Lett. 1982;146:97-100.
31. Hokanson JE, Austin MA, Zambon A, Brunzell JD, Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arterioscler Thromb. 1993;13:427-434.
32. Auwerx JH, Marzetta CA, Hokanson JE. Brunzell JD. Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis. 1989;9:319-325.
33. Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Krauss RM, Beaudrie K, Cone JT. Single vertical spin density gradient ultracentrifugation. Methods Enzymol. 1986;128:181-209.
34. Schumaker VN, Puppione DL. Sequential flotation ultracentrifugation. In: Segrest JP, Albers JJ, eds. Methods in Enzymology, Vol 128, Part A: Plasma Lipoproteins: Preparation, Structure, and Molecular Biology. Orlando, Fla: Academic Press; 1986:155-170.
35. Zambon A, Austin MA, Brown BG, Hokanson JE. Brunzell JD. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb. 1993;13:147-153.
36. Lipid Research Clinics Program. Lipid and lipoprotein analysis. Manual of Laboratory Operations. 2nd ed. Bethesda, Md: US Public Health Service, National Institutes of Health; 1983.
37. 2+ precipitation procedure for quantification of high density lipoprotein cholesterol. Clin Chem. 1982;28:1279-1288.
38. Warnick GR. Enzymatic methods for quantification of lipoprotein lipids. In: Segrest JP. Albers JJ, eds. Methods in Enzymology, Vol 129, Part B: Plasma Lipoproteins. Orlando, Fla: Academic Press Inc; 1986:101-123.
39. Marcovina SM, Albers JJ. International Federation of Clinical Chemistry study on the standardization of apolipoproteins A-I and B. Curr Opin Lipidol. 1991;2:355-361.
40. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem. 1951;193:265-275.
41. Gardner MJ, Altman DG. Calculating confidence intervals from means and their differences. In: Gardner MJ, Altman DG, eds. Statistics With Confidence: Confidence Intervals and Statistical Guidelines. London, England: British Medical Journal. 1989:20-26.
42. Failor RA, Hokanson JE, Brunzell JD. Low density lipoproteins in familial hyperlipidemias. In: Fidge NH, Nestel P, eds. Atherosclerosis, VII. New York, NY: Excerpta Medica; 1986:159-163.
43. Krauss RM, Lindgren FT, Ray RM. Interrelationships among subgroups of serum lipoproteins in normal human subjects. Clin Chim Acta. 1980;104:275-290.
44. Vakakis N, Redgrave TG, Small DM, Castelli WP. Cholesterol content of red blood cells and low density lipoproteins in hypertriglyceridemia. Biochim Biophys Acta. 1983;751:280-285.
45. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: results from the Framingham Offspring Study. Arteriosclerosis. 1987;7:483-490.
46. Haffner SM, Mykkänen L, Valdez RA, Paidi M, Stern MP, Howard BV. LDL size and subclass pattern in a biethnic population. Arterioscler Thromb. 1993;13:1623-1630.
47. Deckelbaum RJ, Granot E, Oschry Y, Rose L, Eisenberg S. Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis. 1984;4:225-231.
48. Deckelbaum RJ, Eisenberg S, Oschry Y, Butbul E, Sharon I, Olivecrona T. Reversible modification of human plasma low density lipoproteins toward triglyceride-rich precursors: a mechanism for losing excess cholesteryl esters. J Biol Chem. 1982;2577:6509-6517.
49. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO Jr. Association of coronary atherosclerosis with hyperapobetali-poproteinemia (increased protein but normal cholesterol levels) in human low density (β) lipoproteins. Proc Natl Acad Sci U S A. 1980;77:604-608.
50. Galeano NF, Milne R, Marcel YL, Walsh MT, Levy E, Ngu'yen T, Gleeson A, Arad Y, Witte L, Al-Haideri M, Rumsey SC, Deckelbaum RJ. Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem. 1994;269:511-519.
51. de Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidization of the dense low-density lipoprotein subfraction in healthy subjects. Arterioscler Thromb, 1991;11:298-306.
52. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subtractions of differing density and particle size. Atherosclerosis. 1992;93:189-199.
53. Chait A, Brazg RL, Tribble DL, Krauss RM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med. 1993;94:350-356.